Intake of <i>Lactobacillus Pentosus TJ515</i> Prevents the Formation of Retinal Edema in Retinal Vein Occlusion Model Mice-Reference-Cited by-同舟云学术

Intake of <i>Lactobacillus Pentosus TJ515</i> Prevents the Formation of Retinal Edema in Retinal Vein Occlusion Model Mice

Published:2023 Issue:2 Volume:6 Page:47-54
ISSN:2434-432X
Container-title:BPB Reports
language:en
Short-container-title:

Author:

Hidaka Yae¹,Kuriyama Aika¹,Nishinaka Anri¹,Takahashi Kei¹,Nakaya Seigo²,Kubota Takeshi²,Nakamura Shinsuke¹,Shimazawa Masamitsu¹,Hara Hideaki³

Affiliation:

1. Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University

2. Sagami Research Laboratory, Wakamoto Pharmaceutical Co., Ltd.

3. Laboratory of Collaborative research for Innovative Drug Discovery, Gifu Pharmaceutical University

Publisher

Pharmaceutical Society of Japan

Subject

General Medicine

Link

https://www.jstage.jst.go.jp/article/bpbreports/6/2/6_47/_pdf

Reference56 articles.

1. 1) Rogers S, McIntosh RL, Cheung N, Lim L, Wang JJ, Mitchell P, Kowalski JW, Nguyen H, Wong TY. The Prevalence of Retinal Vein Occlusion: Pooled Data from Population Studies from the United States, Europe, Asia, and Australia. Ophthalmology, 117, 1–14 (2010).

2. 2) Bodnar ZM, Desai A, Akduman L. Diabetic macular edema. Spectr. Domain Opt. Coherence Tomogr. Macular Dis., 59, 117–127 (2016).

3. 3) Ouyang Y, Heussen FM, Keane PA, Pappuru RKR, Sadda SR, Walsh AC. Evaluation of the axial location of cystoid spaces in retinal vein occlusion using optical coherence tomography. Retina, 33, 1011–1019 (2013).

4. 4) Dvorak HF, Brown LF, Detmar M, Dvorak AM. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am. J. Pathol., 146, 1029–1039 (1995).

5. 5) Cox JT, Eliott D, Sobrin L. Inflammatory complications of intravitreal anti-vegf injections. J. Clin. Med., 10, 1–16 (2021).